Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Other Operating Expenses (2017)

Historic Other Operating Expenses for Monopar Therapeutics (MNPR) over the last 1 years, with Q3 2017 value amounting to $14.5 million.

  • Monopar Therapeutics' Other Operating Expenses changed N/A to $14.5 million in Q3 2017 from the same period last year, while for Jun 2018 it was $14.5 million, marking a year-over-year change of. This contributed to the annual value of $14.5 million for FY2017, which is N/A changed from last year.
  • Monopar Therapeutics' Other Operating Expenses amounted to $14.5 million in Q3 2017.
  • Monopar Therapeutics' Other Operating Expenses' 5-year high stood at $14.5 million during Q3 2017, with a 5-year trough of $14.5 million in Q3 2017.